Image

Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry

Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal is to have a small spectrometer (pocket size) , reliable and rapid tool that can be used during liver harvesting, which enables macrosteatosis to be evaluated reproducibly and selectively, at any time.

This tool must be minimally invasive, inexpensive and without significantly impacting the general organization of multi-organ harvesting.

In the operating room, the surgeon will perform an intraoperative spectrometer scan (five scans on the left lobe) before clamping the aorta. The surgeon will not be informed of the results of the spectrometer, and will carry out (or not) the biopsy. The spectrometers' results will be compared with definitive histological findings.

Eligibility

Inclusion Criteria:

  • Brain-dead donor
  • Age ≥18 years old
  • No restriction on the part of the donor or his family regarding the use of the data for research purposes.
  • No fibrous appearance of the graft (visual assessment), corresponding to a Metavir score ≥ F2

Exclusion Criteria:

  • Living donor
  • Donor within the Maastricht III criteria (cardiac arrest)
  • Pre-existing hepatic injury / trauma preventing the intraoperative use of the pocket spectrometer
  • History of supra-mesocolic surgery or peritonitis leading to perihepatic adhesions (preventing the use of pocket spectrometer)
  • History of chemotherapy -- Biological cholestasis:
    • GGT> 400 IU / L
    • or total bilirubin ≥ 60micromol / L
    • or conjugated bilirubin ≥ 30micromol / L

Study details
    Liver Transplants

NCT05106322

Assistance Publique - Hôpitaux de Paris

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.